Predrag Djurdjević

1.1k total citations
82 papers, 869 citations indexed

About

Predrag Djurdjević is a scholar working on Molecular Biology, Oncology and Pharmacology. According to data from OpenAlex, Predrag Djurdjević has authored 82 papers receiving a total of 869 indexed citations (citations by other indexed papers that have themselves been cited), including 17 papers in Molecular Biology, 17 papers in Oncology and 14 papers in Pharmacology. Recurrent topics in Predrag Djurdjević's work include Antibiotics Pharmacokinetics and Efficacy (10 papers), Chronic Lymphocytic Leukemia Research (8 papers) and Hepatitis C virus research (7 papers). Predrag Djurdjević is often cited by papers focused on Antibiotics Pharmacokinetics and Efficacy (10 papers), Chronic Lymphocytic Leukemia Research (8 papers) and Hepatitis C virus research (7 papers). Predrag Djurdjević collaborates with scholars based in Serbia, United States and Russia. Predrag Djurdjević's co-authors include Milena Jelikić-Stankov, Dejan Baskić, Suzana Popović, Nenad Vuković, Marija Todorović, Milena Vukić, Andrija Ćirić, Nebojša Arsenijević, Ana Obradović and Ivanka Zelen and has published in prestigious journals such as SHILAP Revista de lepidopterología, PLoS ONE and Nutrients.

In The Last Decade

Predrag Djurdjević

74 papers receiving 845 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Predrag Djurdjević Serbia 17 224 188 153 105 94 82 869
Ren-ai Xu China 16 258 1.2× 143 0.8× 146 1.0× 127 1.2× 89 0.9× 93 878
Ravi Shankar Prasad Singh United States 19 225 1.0× 153 0.8× 113 0.7× 62 0.6× 56 0.6× 48 971
Luigi Silvestro Italy 19 358 1.6× 79 0.4× 219 1.4× 112 1.1× 99 1.1× 56 1.1k
Kirstin Thelen Germany 20 191 0.9× 186 1.0× 324 2.1× 111 1.1× 114 1.2× 26 1.3k
James E. Patrick United States 20 277 1.2× 184 1.0× 228 1.5× 164 1.6× 193 2.1× 50 1.4k
Jianghong Fan United States 20 423 1.9× 181 1.0× 357 2.3× 52 0.5× 102 1.1× 45 1.5k
Zhiwei Gao China 20 373 1.7× 92 0.5× 198 1.3× 45 0.4× 57 0.6× 85 1.4k
Xinan Wu China 21 533 2.4× 93 0.5× 272 1.8× 107 1.0× 58 0.6× 121 1.6k
Katsunori Nakamura Japan 24 491 2.2× 165 0.9× 338 2.2× 24 0.2× 114 1.2× 82 1.6k
A. Bernareggi United States 22 399 1.8× 288 1.5× 432 2.8× 78 0.7× 52 0.6× 63 1.3k

Countries citing papers authored by Predrag Djurdjević

Since Specialization
Citations

This map shows the geographic impact of Predrag Djurdjević's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Predrag Djurdjević with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Predrag Djurdjević more than expected).

Fields of papers citing papers by Predrag Djurdjević

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Predrag Djurdjević. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Predrag Djurdjević. The network helps show where Predrag Djurdjević may publish in the future.

Co-authorship network of co-authors of Predrag Djurdjević

This figure shows the co-authorship network connecting the top 25 collaborators of Predrag Djurdjević. A scholar is included among the top collaborators of Predrag Djurdjević based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Predrag Djurdjević. Predrag Djurdjević is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Matić, Sanja, Dragan Milovanović, Željko Mijailović, et al.. (2024). ACE2 and TMPRSS2 genetic polymorphisms as potential predictors of COVID−19 severity and outcome in females. Frontiers in Medicine. 11. 1493815–1493815.
2.
Djordjević, Nataša, Sanja Matić, Dragan Milovanović, et al.. (2023). Effectiveness of a third dose of COVID-19 vaccines against delta variant of SARS-COV-2: A Serbian cohort study. SHILAP Revista de lepidopterología. 151(9-10). 518–524.
3.
Matić, Sanja, Dragan Milovanović, Željko Mijailović, et al.. (2023). IFNL3/4 polymorphisms as a two‐edged sword: An association with COVID‐19 outcome. Journal of Medical Virology. 95(2). e28506–e28506. 5 indexed citations
4.
Matić, Sanja, Dragan Milovanović, Željko Mijailović, et al.. (2023). Its all about IFN‐λ4: Protective role of IFNL4 polymorphism against COVID‐19‐related pneumonia in females. Journal of Medical Virology. 95(10). e29152–e29152. 5 indexed citations
5.
Djikanović, Daniela, et al.. (2022). Spectrofluorimetric and HPLC Determination of Morin in Human Serum. RIMSI - Repository of the Institute for Multidisciplinary Research, Belgrade (University of Belgrade).
6.
Milutinović, Milena, et al.. (2022). Cytotoxic and apoptotic activity of acetone and aqueous Artemisia vulgaris L. and Artemisia alba Turra extracts on colorectal cancer cells. European Journal of Integrative Medicine. 57. 102204–102204. 7 indexed citations
7.
Matić, Sanja, Suzana Popović, Predrag Djurdjević, et al.. (2020). SARS-CoV-2 infection induces mixed M1/M2 phenotype in circulating monocytes and alterations in both dendritic cell and monocyte subsets. PLoS ONE. 15(12). e0241097–e0241097. 28 indexed citations
8.
Vukić, Milena, Nenad Vuković, Suzana Popović, et al.. (2019). Effect of β-cyclodextrin encapsulation on cytotoxic activity of acetylshikonin against HCT-116 and MDA-MB-231 cancer cell lines. Saudi Pharmaceutical Journal. 28(1). 136–146. 28 indexed citations
9.
Milošević-Djordjević, Olivera, et al.. (2018). Apoptosis and genome instability in children with autoimmune diseases. Mutagenesis. 33(5-6). 351–357. 14 indexed citations
10.
11.
Baskić, Dejan, Suzana Popović, Predrag Djurdjević, et al.. (2017). Cytokine profile in chronic hepatitis C: An observation. Cytokine. 96. 185–188. 18 indexed citations
12.
Baskić, Dejan, Danijela Todorović, Predrag Djurdjević, et al.. (2016). Chelidonium majus crude extract inhibits migration and induces cell cycle arrest and apoptosis in tumor cell lines. Journal of Ethnopharmacology. 190. 362–371. 35 indexed citations
13.
Mijailović, Željko, et al.. (2014). 10.5937/mckg48-5925 = Therapy of chronic HCV infection: Association between virological response and predictive factors. SCIDAR. 48(3). 113–121. 1 indexed citations
14.
Zarić, Milan, Marina Mitrović, Ivana Nikolić, et al.. (2014). Chrysin Induces Apoptosis in Peripheral Blood Lymphocytes Isolated from Human Chronic Lymphocytic Leukemia. Anti-Cancer Agents in Medicinal Chemistry. 15(2). 189–195. 14 indexed citations
15.
16.
Djurdjević, Predrag, et al.. (2014). Possible role of CD22, CD79b and CD20 expression in distinguishing small lymphocytic lymphoma from chronic lymphocytic leukemia. Współczesna Onkologia. 1(1). 29–33. 10 indexed citations
17.
Petrović, Dejan, et al.. (2013). Sepsis and cardiorenal syndrome: Etiopathogenesis, diagnosis and treatment. Serbian Journal of Experimental and Clinical Research. 14(4). 181–187. 1 indexed citations
18.
Milošević-Djordjević, Olivera, et al.. (2013). Radioiodine therapy accelerates apoptosis in peripheral blood lymphocytes of patients with differentiated thyroid cancer. Neoplasma. 60(5). 568–575. 8 indexed citations
19.
Zarić, Milan, Marina Mitrović, Ivana Nikolić, et al.. (2011). Activity of superoxide dismutase, catalase and glutathione peroxidase in plasma and lysates of chronic lymphocytic leukemia patients. 45(2). 9–16. 1 indexed citations
20.
Djurdjević, Predrag, et al.. (2004). VALIDATION OF AN HPLC METHOD FOR THE DETERMINATION OF FLEROXACIN AND ITS PHOTO‐DEGRADATION PRODUCTS IN PHARMACEUTICAL FORMS. Annali di Chimica. 94(1-2). 71–83. 3 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Ren-ai Xu Breakdown of academic impact, for papers by Ravi Shankar Prasad Singh Breakdown of academic impact, for papers by Luigi Silvestro Breakdown of academic impact, for papers by Kirstin Thelen Breakdown of academic impact, for papers by James E. Patrick Breakdown of academic impact, for papers by Jianghong Fan Breakdown of academic impact, for papers by Zhiwei Gao Breakdown of academic impact, for papers by Xinan Wu Breakdown of academic impact, for papers by Katsunori Nakamura Breakdown of academic impact, for papers by A. Bernareggi
Rankless by CCL
2026